1 |
CK2 Contributes to the Synergistic Effects of BMP7 and BDNF on Smad 1/5/8 Phosphorylation in Septal NeuronsChaverneff, Florence 19 December 2008 (has links)
The combination of bone morphogenetic protein 7 (BMP7) and neurotrophins (e.g. brain-derived neurotrophic factor, BDNF) protects septal neurons during hypoglycemic stress. I investigated the signaling mechanisms underlying this synergistic protection. BMP7 (5 nM) increased phosphorylation and nuclear translocation of BMP-responsive Smads 1/5/8 within 30 min in cultures of rat embryonic septal neurons. BDNF (100 ng/ml) enhanced the BMP7-induced increase in phospho-Smad levels in both nucleus and cytoplasm; this effect was more pronounced after a hypoglycemic stress. BDNF increased both Akt and Erk phosphorylation, but pharmacological blockade of these kinase pathways (with wortmannin and U0126, respectively) did not reduce the Smad phosphorylation produced by the BMP7+BDNF combination. Inhibitors of casein kinase II (CK2) activity reduced the (BMP7 + BDNF)-induced Smad phosphorylation, and this trophic factor combination increased CK2 activity in hypoglycemic cultures. These findings suggest that BDNF can increase BMP-dependent Smad phosphorylation via a mechanism requiring CK2. Preliminary results indicate that a cytoplasmic component robustly inhibits CK2. Protection of septal cholinergic neurons during a hypoglycemic stress is inhibited by a CK2 inhibitor and by a Phosphatidylinositol 3-kinase inhibitor, indicating that increases in CK2 activity and in Smad phosphorylation are only part on the protective mechanisms.
|
2 |
Genomic integration of Wnt/β-catenin and BMP/Smad1 signaling coordinates digestive system developmentStevens, Mariana L. 07 September 2017 (has links)
No description available.
|
3 |
Utilization of gene knockout approaches in the mouse to elucidate additional functions of smad proteins during mammalian developmentHester, Mark 04 August 2005 (has links)
No description available.
|
4 |
Osteogenic Regulatory Mechanisms Activated By Pressure In Aortic Heart ValveGamez, Carol Andrea Pregonero 11 December 2009 (has links)
Calcific aortic valve disease (CAVD) is the most common cause of aortic valve failure and replacement in the elderly population, affecting 25% of the population over 65 years of age. Current pharmacological approaches for preventing the onset and progression of calcific aortic valve disease have not shown consistent benefits in clinical studies. Differentiation of valvular interstitial cells (VICs) into osteoblast–like cells is an integral step in the calcification process. Although clinical evidence suggests hypertension as a potential candidate contributing to the development of CAVD, the underlying molecular mechanisms that cause de-differentiation remain unclear. The present study investigates the role of elevated cyclic pressure in modulating osteoblast differentiation pathways in VICs in vitro. We used a combination of systems biology modeling and pathway-based analyses to identify novel genes and molecular mechanisms that are activated in valve tissue during exposure to elevated pressure conditions. Our results show that elevated pressure induces a gene expression pattern in valve tissue that is considerably similar to that seen in CAVD, underlining the key role of hypertension as an initiating factor in the onset of pathogenesis. In addition, our analysis revealed a set of genes that was not previously known to be regulated in valve tissue in a pressure dependent manner. Currently, the molecular mechanisms involved in CAVD and their associations with changes in local mechanical environment are poorly understood, and thus a better understanding of the cell based process mediating CAVD progression will improve our ability to develop potential medical therapies for this disease.
|
5 |
TRANSCRIPTIONAL REGULATION OF OSTEOACTIVIN EXPRESSION BY BMP-2 IN OSTEOBLASTSSingh, Maneet January 2011 (has links)
Osteoactivin (OA) is a glycoprotein required for the differentiation of osteoblasts. In osteoblasts, Bone Morphogenetic Protein-2 (BMP-2) activated Smad1 signaling enhances OA expression. However, the transcriptional regulation of OA gene expression by BMP-2 is still unknown. The aim of this study was to characterize BMP-2-induced transcription factors that regulate OA gene expression during osteoblast differentiation. The stimulatory effects of BMP-2 on OA transcription were established by cloning the proximal 0.96kb of rat OA promoter region in a luciferase reporter vector in various osteogenic cell types. Further, by deletion and mutagenesis analyses of the cloned OA promoter, key binding sites for osteogenic transcription factors namely, Runx2, Smad1, Smad4 and homeodomain proteins (Dlx3, Dlx5 and Msx2) were identified and characterized. Utilizing specific siRNAs to knock down Runx2, Smad1, Smad4, Dlx3, Dlx5 or Msx2 proteins in osteoblasts, we found that Runx2, Smad1, Smad4, Dlx3 and Dlx5 proteins up-regulate OA transcription, whereas, Msx2 down-regulated OA gene expression. These specific effects of transcription factors on OA promoter regulation were confirmed by forced expression of transcription factors. Most notably, BMP-2-stimulated cooperative and synergistic interactions between Runx2-Smad1 proteins and Dlx3-Dlx5 proteins that up-regulate OA promoter activity. Electrophoretic mobility shift and supershift assays demonstrated that BMP-2 stimulates interactions between Runx2, Smad1 and Smad4 and homeodomain transcription factors with the OA promoter regions flanking the -585 Runx2 binding site, the -248 Smad binding site and the region between the -852 and the -843 homeodomain binding sites relative to transcription start site. The OA promoter region was occupied by Runx2 and also Dlx3 transcription factors during proliferation stages of osteoblast differentiation. As the osteoblasts progress from proliferation to matrix maturation stages of differentiation, the OA promoter was predominantly occupied by Runx2 and to a lesser extent Dlx5 in response to BMP-2. Finally, during matrix mineralization stages of osteoblast differentiation, BMP-2-induced a robust recruitment of Dlx5, Smad1, Dlx3 and Msx2 proteins with simultaneous dissociation of Runx2 from the OA promoter region. In conclusion, the BMP-2-induced osteogenic transcription factors Runx2, Smad1, Smad4, Dlx3, Dlx5 and Msx2 provide key molecular switches that regulate OA transcription during osteoblast differentiation. / Cell Biology
|
6 |
Cdx-mediated co-integration of Wnt and BMP signals on a single Pax3 neural crest enhancerLaberge Perrault, Emilie 09 1900 (has links)
Chez les vertébrés, une première ébauche du système nerveux central à partir du neurectoderme est obtenue par la neurulation. Ce processus mène à la formation du tube neural (TN) à partir de la plaque neurale. La neurulation est coordonnée avec l’induction d’une population de cellules multipotentes aux bordures latérales de la plaque neurale: les cellules de la crête neurale (CCNs). Le gène Pax3 encode un facteur de transcription qui est essentiel pour la formation du TN et des CCNs. Une petite région régulatrice d’environ ~250pb dans le promoteur proximal de Pax3, appelée NCE2, est suffisante pour récapituler l’induction de Pax3 ainsi que sa restriction aux bordures latérales de la plaque neurale. Le NCE2 de Pax3 est connu pour intégrer des signaux instructifs antéropostérieur (AP) provenant de la voie Wnt, via les protéines CDX (CDX 1, 2, 4), pouvant induire l'expression de Pax3 dans la plaque neurale postérieure (PNP). Nous avons démontré ici que, en plus des signaux AP, le NCE2 de Pax3 intègre des signaux instructifs dorsoventraux (DV) provenant de la voie BMP, via ses effecteurs SMAD1/5. Nos résultats indiquent que les protéines SMAD1/5 pourraient être le cofacteur manquant dans le contrôle CDX-dépendant de l’expression de Pax3 et que ce serait ces protéines qui permettraient de conférer le patron d’expression restreint de Pax3 aux bordures latérales de la PNP. Pour étayer cette affirmation, nous fournissons de nouvelles preuves que l’activité de BMP-SMAD1/5 sur l’expression de Pax3 est médiée par les CDX. Comme des défauts affectant la formation du TN et des CCNs sont à la base de plusieurs syndromes génétiques et malformations congénitales chez l’humain, nos résultats offrent ainsi une meilleure compréhension des mécanismes moléculaires sous-tendant ces pathologies. / In vertebrates, a first draft of the central nervous system from the neurectoderm is obtained by neurulation. This process leads to the formation of the neural tube (NT) from the neural plate. Neurulation is coordinated with the induction of a population of multipotent cells at the neural plate border: neural crest cells (NCCs). The Pax3 gene encodes a transcription factor that is essential for the formation of the NT and NCCs. A small regulatory region of ~250bp in the proximal promoter of Pax3, called NCE2, is sufficient to recapitulate the induction of Pax3 and its restriction to the lateral borders of the neural plate. The Pax3NCE2 is known to incorporate anterior-posterior (AP) instructive cues from the Wnt pathway, via CDX proteins (CDX1, 2, 4), which can induce the expression of Pax3 in the posterior neural plate (PNP). We have demonstrated that, in addition to the AP cues, Pax3NCE2 integrates instructive dorsal-ventral (DV) cues from the BMP pathway, via SMAD1/5 proteins. Our results indicate that SMAD1/5 proteins could be the missing co-factor in the CDX-dependent expression of Pax3 that restrict Pax3 expression to the lateral borders of the PNP. To support this assertion, we provide further evidence that the activity of BMP-SMAD1/5 on the expression of Pax3 is mediated by CDX proteins. As defects affecting the formation of the NT and NCCs are the basis of many genetic syndromes and birth defects in humans, our results provide a better understanding of the molecular mechanisms underlying these pathologies.
|
7 |
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionNasim, Md. Talat, Ogo, T., Ahmed, Mohammed I., Randall, R., Chowdhury, H.M., Snape, K.M., Bradshaw, T.Y., Southgate, L., Lee, G.J., Jackson, I., Lord, G.M., Gibbs, J.S., Wilkins, M.R., Ohta-Ogo, K., Nakamura, K., Girerd, B., Coulet, F., Soubrier, F., Humbert, M., Morrell, N.W., Trembath, R.C., Machado, R.D. January 2011 (has links)
Yes / Heterozygous germline mutations of BMPR2 contribute to familial clustering of pulmonary arterial hypertension (PAH). To further explore the genetic basis of PAH in isolated cases, we undertook a candidate gene analysis to identify potentially deleterious variation. Members of the bone morphogenetic protein (BMP) pathway, namely SMAD1, SMAD4, SMAD5, and SMAD9, were screened by direct sequencing for gene defects. Four variants were identified in SMADs 1, 4, and 9 among a cohort of 324 PAH cases, each not detected in a substantial control population. Of three amino acid substitutions identified, two demonstrated reduced signaling activity in vitro. A putative splice site mutation in SMAD4 resulted in moderate transcript loss due to compromised splicing efficiency. These results demonstrate the role of BMPR2 mutation in the pathogenesis of PAH and indicate that variation within the SMAD family represents an infrequent cause of the disease.
|
Page generated in 0.0244 seconds